Russell Investments Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $132M | Buy |
5,482,863
+745,213
| +16% | +$19.5M | 0.12% | 165 |
|
|
2026
Q1 | $133M | Sell |
4,737,650
-480,835
| -9% | -$12.8M | 0.14% | 145 |
|
|
2025
Q4 | $130M | Buy |
5,218,485
+911,348
| +21% | +$23M | 0.14% | 138 |
|
|
2025
Q3 | $109M | Buy |
4,307,137
+328,783
| +8% | +$8.12M | 0.12% | 171 |
|
|
2025
Q2 | $96.4M | Buy |
3,978,354
+446,069
| +13% | +$10.4M | 0.12% | 174 |
|
|
2025
Q1 | $89.5M | Sell |
3,532,285
-266,185
| -7% | -$6.97M | 0.12% | 171 |
|
|
2024
Q4 | $101M | Buy |
3,798,470
+73,526
| +2% | +$1.99M | 0.14% | 140 |
|
|
2024
Q3 | $108M | Buy |
3,724,944
+933,358
| +33% | +$27.2M | 0.16% | 138 |
|
|
2024
Q2 | $78.1M | Buy |
2,791,586
+26,786
| +1% | +$737K | 0.13% | 167 |
|
|
2024
Q1 | $76.7M | Sell |
2,764,800
-171,533
| -6% | -$4.76M | 0.12% | 176 |
|
|
2023
Q4 | $84.5M | Sell |
2,936,333
-853,282
| -23% | -$25.8M | 0.15% | 148 |
|
|
2023
Q3 | $126M | Buy |
3,789,615
+466,800
| +14% | +$16.5M | 0.25% | 72 |
|
|
2023
Q2 | $122M | Sell |
3,322,815
-260,427
| -7% | -$10.1M | 0.24% | 78 |
|
|
2023
Q1 | $146M | Buy |
3,583,242
+691,406
| +24% | +$29.9M | 0.29% | 57 |
|
|
2022
Q4 | $148M | Sell |
2,891,836
-44,539
| -2% | -$2.14M | 0.31% | 54 |
|
|
2022
Q3 | $129M | Buy |
2,936,375
+60,546
| +2% | +$2.94M | 0.28% | 59 |
|
|
2022
Q2 | $151M | Sell |
2,875,829
-1,520,166
| -35% | -$77.5M | 0.31% | 53 |
|
|
2022
Q1 | $228M | Sell |
4,395,995
-200,052
| -4% | -$10.4M | 0.4% | 31 |
|
|
2021
Q4 | $271M | Sell |
4,596,047
-332,980
| -7% | -$16.5M | 0.43% | 26 |
|
|
2021
Q3 | $212M | Sell |
4,929,027
-682,281
| -12% | -$30.2M | 0.36% | 37 |
|
|
2021
Q2 | $220M | Sell |
5,611,308
-337,088
| -6% | -$13.1M | 0.37% | 35 |
|
|
2021
Q1 | $215M | Sell |
5,948,396
-440,749
| -7% | -$15.6M | 0.38% | 32 |
|
|
2020
Q4 | $235M | Sell |
6,389,145
-1,770,635
| -22% | -$64.9M | 0.47% | 21 |
|
|
2020
Q3 | $283M | Sell |
8,159,780
-1,186,127
| -13% | -$41.6M | 0.61% | 17 |
|
|
2020
Q2 | $290M | Buy |
9,345,907
+174,143
| +2% | +$5.92M | 0.65% | 15 |
|
|
2020
Q1 | $284M | Sell |
9,171,764
-827,912
| -8% | -$28.2M | 0.74% | 13 |
|
|
2019
Q4 | $371M | Sell |
9,999,676
-673,392
| -6% | -$24M | 0.69% | 16 |
|
|
2019
Q3 | $365M | Sell |
10,673,068
-695,202
| -6% | -$25.3M | 0.71% | 13 |
|
|
2019
Q2 | $468M | Sell |
11,368,270
-1,626,398
| -13% | -$64.6M | 0.87% | 9 |
|
|
2019
Q1 | $523M | Buy |
12,994,668
+2,289,037
| +21% | +$91.7M | 0.97% | 8 |
|
|
2018
Q4 | $441M | Sell |
10,705,631
-406,911
| -4% | -$16.9M | 0.99% | 7 |
|
|
2018
Q3 | $464M | Sell |
11,112,542
-729,507
| -6% | -$28.1M | 0.88% | 7 |
|
|
2018
Q2 | $408M | Sell |
11,842,049
-3,481,390
| -23% | -$119M | 0.85% | 9 |
|
|
2018
Q1 | $515M | Buy |
15,323,439
+284,086
| +2% | +$9.77M | 0.87% | 12 |
|
|
2017
Q4 | $519M | Buy |
15,039,353
+1,082,858
| +8% | +$36.9M | 0.87% | 9 |
|
|
2017
Q3 | $473M | Buy |
13,956,495
+323,505
| +2% | +$10.4M | 0.81% | 11 |
|
|
2017
Q2 | $435M | Sell |
13,632,990
-40,315
| -0.3% | -$1.27M | 0.77% | 11 |
|
|
2017
Q1 | $444M | Buy |
13,673,305
+1,182,177
| +9% | +$37.3M | 0.81% | 11 |
|
|
2016
Q4 | $385M | Buy |
+12,491,128
| New | +$381M | 0.75% | 10 |
|
Other funds holding PFE
Russell Investments Group's PFE Position: Q2 2026 in Review
Russell Investments Group increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $19.5M and bringing the position to 5,482,863 shares worth $132M. The position accounts for 0.12% of the portfolio, ranked #165.
Russell Investments Group first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $523M in Q1 2019. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Russell Investments Group held 5,482,863 shares of Pfizer worth $132M as of Q2 2026.
- Russell Investments Group bought 745,213 Pfizer shares in Q2 2026, an estimated $19.5M.
- Pfizer made up 0.12% of Russell Investments Group's portfolio in Q2 2026, its #165 holding.
- Russell Investments Group first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
- Russell Investments Group's Pfizer position peaked at $523M in Q1 2019.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.